These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 6649025)

  • 1. Characterization of biochemical changes occurring during storage of red cells. Comparative studies with CPD and CPDA-1 anticoagulant-preservative solutions.
    Moroff G; Dende D
    Transfusion; 1983; 23(6):484-9. PubMed ID: 6649025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and biochemical characteristics of stored red cells preserved with citrate-phosphate-dextrose-adenine-one and two and prepared from whole blood maintained at 20 to 24 degrees C for eight hours following phlebotomy.
    Moroff G; Morse EE; Katz AJ; Kahn RA; Dende D; Swatman L; Staggs SD
    Transfusion; 1984; 24(2):115-9. PubMed ID: 6710583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo viability of red blood cells stored in CPDA-2.
    Sohmer PR; Moore GL; Beutler E; Peck CC
    Transfusion; 1982; 22(6):479-84. PubMed ID: 7147326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of irradiation on red cells stored in CPDA-1 and CPD-ADSOL (AS-1).
    Jeter EK; Gadsden RH; Cate J
    Ann Clin Lab Sci; 1991; 21(3):177-86. PubMed ID: 1905899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The biochemical effects of CPDA-2-drawn red blood cells of delayed refrigeration prior to component preparation.
    Moore GL; Ledford ME; Merydith A
    Transfusion; 1982; 22(6):485-7. PubMed ID: 7147327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell storage for 56 days in modified DPD-adenine. An in vitro evaluation.
    Moore GL; Ledford ME; Unruh KA; Brummell MR
    Transfusion; 1981; 21(6):699-701. PubMed ID: 7314217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroxyacetone, pyruvate, and phosphate effects on 2,3 DPG and ATP in citrate-phosphate-dextrose-adenine blood preservation.
    Dawson RB; Fagan DS; Meyer DR
    Transfusion; 1984; 24(4):327-9. PubMed ID: 6464157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3-diphosphoglycerate.
    Kurup PA; Arun P; Gayathri NS; Dhanya CR; Indu AR
    Vox Sang; 2003 Nov; 85(4):253-61. PubMed ID: 14633250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viability and function of red blood cell concentrates stored at 4 degrees C for 35 days in CPDA-1, CPDA-2, or CPDA-3.
    Valeri CR; Valeri DA; Gray A; Melaragno A; Dennis RC; Emerson CP
    Transfusion; 1982; 22(3):210-6. PubMed ID: 7090034
    [No Abstract]   [Full Text] [Related]  

  • 10. The in vitro evaluation of modifications in CPD-adenine anticoagulated-preserved blood at various hematocrits.
    Moore GL; Ledford ME; Peck CC
    Transfusion; 1980; 20(4):419-26. PubMed ID: 7404640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Storage of red cell concentrates in CPD-A2 for 42 and 49 days.
    Beutler E; West C
    J Lab Clin Med; 1983 Jul; 102(1):53-62. PubMed ID: 6854134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red cell ATP and 2,3-diphosphoglycerate concentrations as a function of dihydroxyacetone supplementation of CPD adenine.
    Moore GL; Ledford ME; Brummell MR
    Vox Sang; 1981; 41(1):11-7. PubMed ID: 7324438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell aging markers during storage in citrate-phosphate-dextrose-saline-adenine-glucose-mannitol.
    Antonelou MH; Kriebardis AG; Stamoulis KE; Economou-Petersen E; Margaritis LH; Papassideri IS
    Transfusion; 2010 Feb; 50(2):376-89. PubMed ID: 19874562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 24-hour posttransfusion survival, oxygen transport function, and residual hemolysis of human outdated-rejuvenated red cell concentrates after washing and storage at 4 degrees C for 24 to 72 hours.
    Valeri CR; Gray AD; Cassidy GP; Riordan W; Pivacek LE
    Transfusion; 1984; 24(4):323-6. PubMed ID: 6464156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manufacture of red cells in additive solution from whole blood refrigerated for 5 days or remanufactured from red cells stored in plasma.
    Wiltshire M; Cardigan R; Thomas S
    Transfus Med; 2010 Dec; 20(6):383-91. PubMed ID: 20681977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Storage of saline-adenine-glucose-mannitol-suspended red cells in a new plastic container: polyvinylchloride plasticized with butyryl-n-trihexyl-citrate.
    Högman CF; Eriksson L; Ericson A; Reppucci AJ
    Transfusion; 1991 Jan; 31(1):26-9. PubMed ID: 1898784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthone additives for blood storage that maintain its potential for oxygen delivery. I. 2-Hydroxyethoxy- and 2-ethoxy-6-(5-tetrazoyl) xanthones in citrate-phosphate-dextrose-adenine (CPDA-1) blood.
    Paterson RA; Dawson J; Hyde RM; Livingstone DJ; Parry ES; Nash S; Boyce IM
    Transfusion; 1988; 28(1):34-7. PubMed ID: 3341063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use.
    Högman CF; Eriksson L; Gong J; Högman AB; Vikholm K; Debrauwere J; Payrat JM; Stewart M
    Vox Sang; 1993; 65(4):271-8. PubMed ID: 8310679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the anticoagulant-preservative citrate-phosphate-adenine (CPDA-1) on blood services.
    McEvoy PM; Kahn RA; Miller WV
    Transfusion; 1982; 22(6):532-4. PubMed ID: 7147334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adequate survival of red cells from units "undercollected" in citrate-phosphate-dextrose-adenine-one.
    Davey RJ; Lenes BL; Casper AJ; Demets DL
    Transfusion; 1984; 24(4):319-22. PubMed ID: 6464155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.